Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HEG1 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | ZER1 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | UBE2N | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | KLHL8 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | MRPS31 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | RNF8 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | SNRPF | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | SDHAF3 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | UBE3D | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | HNRNPDL | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |